Overview
Dissemination of evidence reviews about the safety of medicines and vaccines from around the world.
The DSRU Global Pharmacovigilance Observatory aims to bring together data about the safety of medicines and vaccines from regulatory authorities and other data sources of multiple countries into one place.
View more
Pharmacovigilance Evidence Reviews
Assessing Case Fatality on Cases of Thrombosis with Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data
Samantha Lane & Saad Shakir As we have said before, pharmacovigilance has moved on from the initial phase of assessing...
Myocarditis and Pericarditis following mRNA COVID-19 Vaccines
Professor Saad Shakir During the first 18 months of the pandemic, pharmacovigilance focussed on the immediate urgent tasks for assessing...
Assessing Case Fatality on Cases of Thrombosis with Thrombocytopenia (TTS) Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data
(Pre-peer reviewed publication) The DSRU Global Pharmacovigilance Observatory recently completed a review of spontaneously reported adverse events data from the...
Summary: Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
Two years after the start of the COVID-19 pandemic, the scientific response to the SARS-CoV-2 virus is transitioning from the...
The UK is one of the best countries in the world for carrying out observational pharmacoepidemiologic studies
The UK healthcare system has many qualities which make it ideal for carrying out observational research. Observational research is complementary...
Vaccination provides weaker COVID-19 protection for immunocompromised patients
The DSRU Global Pharmacovigilance Observatory recently completed a systematic review of multiple studies comparing the immune response to COVID-19 vaccines...